FundedIQ
Biotechnology

Rejoni: Funding, Investors & Team (Sep 2026)

At Rejoni, our team is working on developing solutions that minimize both acute and chronic risks associated with gynecologic procedures by providing women’s health-centered technologies that help women to achieve the life they want both now and in the future.

www.rejoni.com LinkedIn Bedford, United States 1-10 employees
Biotechnology Health Care Health Diagnostics Medical Device
Total raised
$50.0M
Rounds
2
Latest
Undisclosed round
Jun 2026

Rejoni has raised $50.0M across 2 funding rounds on record, the most recent an undisclosed round of $25.0M announced in Jun 2026.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Rejoni Company Profile and Key Stats

Total funding raised
$50.0M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$25.0M in Jun 2026
Employees
1-10
reported band
Headquarters
Bedford, United States

Latest funding round on record: Jun 2026.

Rejoni Funding Rounds

Date
Round
Amount
Undisclosed round
$25.0M
Series B
$25.0M

Rejoni raised $25.0M in a Series B announced in Dec 2022.

3.5 years later, an undisclosed round of $25.0M was announced in Jun 2026.

Rejoni Founders and Leadership Team

Name
Role
Contact
John Nealon
Founder
Amarpreet Sawhney
CEO

No contact details are on record for this team yet.

Rejoni Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M

Rejoni's latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Rejoni in Biotechnology and Bedford

Companies Similar to Rejoni

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Rejoni Funding FAQs

What does Rejoni do?

At Rejoni, our team is working on developing solutions that minimize both acute and chronic risks associated with gynecologic procedures by providing women’s health-centered technologies that help women to achieve the life they want both now and in the future.

How much funding has Rejoni raised?

Rejoni has raised $50.0M across 2 rounds on record. The most recent is an undisclosed round of $25.0M announced in Jun 2026.

When did Rejoni last raise funding?

Rejoni's most recent funding round on record is an undisclosed round of $25.0M, announced in Jun 2026.

Who founded Rejoni?

FundedIQ lists John Nealon (Founder) at Rejoni.

Who is the CEO of Rejoni?

Amarpreet Sawhney is listed as CEO at Rejoni.

Where is Rejoni headquartered?

Rejoni is based in Bedford, Massachusetts, United States.

How many employees does Rejoni have?

Rejoni is in the 1-10 employee band.

How does Rejoni's funding compare to other Biotechnology startups?

Rejoni's latest round of $25.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's Rejoni Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rejoni is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.